Uptake and mode of action of drugs used against sleeping sickness. (Q34118095)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11137702 AND SRC:MED&resulttype=core&format=json

3 November 2019

review article

1 reference

title

Uptake and mode of action of drugs used against sleeping sickness (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11137702 AND SRC:MED&resulttype=core&format=json

3 November 2019

main subject

African trypanosomiasis

0 references

author

Hubert Denise

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11137702 AND SRC:MED&resulttype=core&format=json

3 November 2019

Michael P. Barrett

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11137702 AND SRC:MED&resulttype=core&format=json

3 November 2019

author name string

Barrett MP

series ordinal

2

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11137702 AND SRC:MED&resulttype=core&format=json

3 November 2019

published in

Biochemical Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11137702 AND SRC:MED&resulttype=core&format=json

3 November 2019

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11137702 AND SRC:MED&resulttype=core&format=json

3 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11137702 AND SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

1-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11137702 AND SRC:MED&resulttype=core&format=json

The fall and rise of sleeping sickness

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

Surface receptors and transporters of Trypanosoma brucei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

The uptake of the trypanocidal drug suramin in combination with low-density lipoproteins by Trypanosoma brucei and its possible mode of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

Anti-sleeping Sickness Drugs and Cancer Chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

Arsenical-resistant trypanosomes lack an unusual adenosine transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

The structure and replication of kinetoplast DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

Uptake of diamidine drugs by the P2 nucleoside transporter in melarsen-sensitive and -resistant Trypanosoma brucei brucei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

Mel B in the treatment of human trypanosomiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

A diamidine-resistant Trypanosoma equiperdum clone contains a P2 purine transporter with reduced substrate affinity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

The biochemical basis of arsenical-diamidine crossresistance in African trypanosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

An approach to use an unusual adenosine transporter to selectively deliver polyamine analogues to trypanosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

Effects of various metabolic conditions and of the trivalent arsenical melarsen oxide on the intracellular levels of fructose 2,6-bisphosphate and of glycolytic intermediates in Trypanosoma brucei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

Affinity chromatography using trypanocidal arsenical drugs identifies a specific interaction between glycerol-3-phosphate dehydrogenase from Trypanosoma brucei and Cymelarsan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

The interaction of arsenical drugs with dihydrolipoamide and dihydrolipoamide dehydrogenase from arsenical resistant and sensitive strains of Trypanosoma brucei brucei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

Ornithine decarboxylase as an enzyme target for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

Uptake of alpha-difluoromethylornithine by Trypanosoma brucei brucei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

A Trypanosoma brucei mutant resistant to alpha-difluoromethylornithine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

Biochemical changes associated with alpha-difluoromethylornithine uptake and resistance in Trypanosoma brucei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

Alterations in ornithine decarboxylase characteristics account for tolerance of Trypanosoma brucei rhodesiense to D,L-alpha-difluoromethylornithine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

Mechanism of nifurtimox toxicity in different forms of Trypanosoma cruzi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

High-dose nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness: an open trial in central Zaire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

Comparative studies of nifurtimox uptake and metabolism by drug-resistant and susceptible strains of Trypanosoma cruzi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

Sensitivity of parasites to free radical damage by antiparasitic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

"Subversive" substrates for the enzyme trypanothione disulfide reductase: alternative approach to chemotherapy of Chagas disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

A nitroimidazole-thiadiazole derivative with curative action in experimental Trypanosoma cruzi infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

Megazol combined with suramin: a chemotherapy regimen which reversed the CNS pathology in a model of human African trypanosomiasis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

Uptake of the nitroimidazole drug megazol by African trypanosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

Enzymatic reduction studies of nitroheterocycles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

CL 64,855, a potent anti-Trypanosoma cruzi drug, is also mutagenic in the Salmonella/microsome assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

Compartmentation of carbohydrate metabolism in trypanosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

Metabolism and functions of trypanothione in the Kinetoplastida

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

Recent advances in identifying and validating drug targets in trypanosomes and leishmanias.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

Prospects for antiparasitic drugs. The case of Trypanosoma brucei, the causative agent of African sleeping sickness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

Perspectives in research on and control of African trypanosomiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

The treatment of human African trypanosomiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Adenosine transporters in bloodstream forms of Trypanosoma brucei brucei: substrate recognition motifs and affinity for trypanocidal drugs

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00477-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-2952(00)00477-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11137702 AND SRC:MED&resulttype=core&format=json

3 November 2019

1 reference